Last reviewed · How we verify
BIIB0121 and Antacid — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
BIIB0121 and Antacid (BIIB0121 and Antacid) — Biogen.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| BIIB0121 and Antacid TARGET | BIIB0121 and Antacid | Biogen | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- BIIB0121 and Antacid CI watch — RSS
- BIIB0121 and Antacid CI watch — Atom
- BIIB0121 and Antacid CI watch — JSON
- BIIB0121 and Antacid alone — RSS
Cite this brief
Drug Landscape (2026). BIIB0121 and Antacid — Competitive Intelligence Brief. https://druglandscape.com/ci/biib0121-and-antacid. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab